Design And Characterization of Chitosan Nanoparticles Containing Telmisartan for Controlled Drug Delivery System
Authors/Creators
- 1. Department of Pharmaceutics, JKK Munirajahh Institute of Health Sciences College of Pharmacy, Gobichettipalayam, Erode, Tamilnadu, India- 638506.
Description
Abstract
This study aimed to formulate and evaluate Telmisartan-loaded chitosan nanoparticles using the ionic gelation technique to enhance drug solubility, bioavailability and achieve sustained drug release. Telmisartan-loaded chitosan nanoparticles were prepared by ionic gelation using chitosan as the polymer and sodium tripolyphosphate (STPP) as the cross-linking agent. Formulations were optimized by varying polymer concentration and sonication time. The prepared nanoparticles were characterized for particle size, zeta potential, morphology, drug entrapment efficiency and in vitro drug release. Drug–polymer compatibility was assessed using Fourier Transform Infrared (FTIR) spectroscopy. The optimized formulation exhibited a mean particle size of approximately 180 nm, a positive zeta potential indicating good colloidal stability and an entrapment efficiency exceeding 85%. The in-vitro drug release profile demonstrated a sustained, controlled release following zero-order kinetics with a non-Fickian diffusion mechanism. In vitro release studies demonstrated sustained drug release over 24 hours with improved dissolution compared to the marketed formulation.
Keywords
Telmisartan, Chitosan nanoparticles, Ionic gelation, Sustained drug release.
Files
98-107-Selvaraj-7680659494.pdf
Files
(917.8 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:f253006ca46b4cff44415915bfebf0a7
|
917.8 kB | Preview Download |
Additional details
References
- 1. World Health Organization. Guideline for the pharmacological treatment of hypertension in adults. Geneva: World Health Organization; 2021. 2. International Society of Hypertension. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension. 2020;75(6):1334–57. 3. Britt H, Nabi S. Telmisartan: Pharmacology, pharmacokinetics and clinical efficacy. Clin Pharmacokinet. 2001;40(9):647–64. 4. Amidon GL, Lennernäs H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res. 1995;12(3):413–20. 5. Dash M, Chiellini F, Ottenbrite RM, Chiellini E. Chitosan—A versatile semi-synthetic polymer in biomedical applications. Prog Polym Sci. 2011;36(8):981–1014. 6. Calvo P, Remuñán-López C, Vila-Jato JL, Alonso MJ. Novel hydrophilic chitosan–polyethylene oxide nanoparticles as protein carriers. J Appl Polym Sci. 1997;63(1):125–32. 7. Agnihotri SA, Mallikarjuna NN, Aminabhavi TM. Recent advances on chitosan-based micro- and nanoparticles in drug delivery. J Control Release. 2004;100(1):5–28. 8. Fan W, Yan W, Xu Z, Ni H. Formation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation technique. Colloids Surf B Biointerfaces. 2012; 90:21–7. 9. Gan Q, Wang T. Chitosan nanoparticle as protein delivery carrier—Systematic examination of fabrication conditions. Colloids Surf B Biointerfaces. 2007;59(1):24–34. 10. Mohanraj VJ, Chen Y. Nanoparticles – A review. Trop J Pharm Res. 2006;5(1):561–73. 11. Grenha A, Seijo B, Remuñán-López C. Microencapsulated chitosan nanoparticles for lung protein delivery. Eur J Pharm Sci. 2005;25(4–5):427–37. 12. Hu B, Pan C, Sun Y, Hou Z, Ye H, Hu B, et al. Optimization of fabrication parameters to produce chitosan–tripolyphosphate nanoparticles for delivery of tea catechins. J Agric Food Chem. 2008;56(16):7451–8. 13. Ritger PL, Peppas NA. A simple equation for description of solute release II. Fickian and anomalous release from swellable devices. J Control Release. 1987;5(1):37–42. 14. Higuchi T. Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci. 1963;52(12):1145–9. 15. Bernkop-Schnürch A, Dünnhaupt S. Chitosan-based drug delivery systems. Eur J Pharm Biopharm. 2012;81(3):463–9. 16. Sarmento B, Ferreira D, Veiga F, Ribeiro A. Characterization of insulin-loaded alginate nanoparticles produced by ionotropic pre-gelation through DSC and FTIR studies. Carbohydr Polym. 2006;66(1):1–7.